🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Connecticut › Hartford

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Hartford, CT

12 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Hartford (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04267848

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Mengambil pesertaFasa 3
  • University of Connecticut Health Center ( Site 0130), Farmington · 8 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07190248

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • Hartford Hospital, Hartford
  • Hartford HealthCare - Avon, Avon · 8 mi jauh
  • Hartford HealthCare - Manchester, Manchester · 8 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Hartford Hospital (HH), Hartford
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06890598

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Mengambil pesertaFasa 2
  • Hartford Healthcare, Hartford
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Feb 2026 · NCT03808337

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Mengambil pesertaFasa 1/2
  • Hartford Hospital (site 210), Hartford
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Dis 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Hartford
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Hartford

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.